ArticleIEEE transactions on bio-medical engineering2026
FOSTER: A Comprehensive Pipeline for Transabdominal Fetal Pulse Oximetry Validated in a Large Animal Model of Pregnancy.
Article in IEEE transactions on bio-medical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTransabdominal fetal pulse oximetry (TFO) has the potential to supplement present intrapartum fetal monitoring approaches, which cannot accurately detect fetuses at risk of birth asphyxia. However, non-invasive measurement of fetal oxygen saturation (fSpO$_{2}$) is challenging due to dominant maternal tissue signals. We present methods to overcome such challenges, enabling robust and continuous fSpO$_{2}$ measurement.
methodsWe introduce FOSTER (Fetal Oxygen SaTuration EstimatoR), a comprehensive pipeline that combines novel signal processing and machine learning techniques to process photoplethysmogram (PPG) signals and estimate continuous fSpO$_{2}$. Using controlled desaturation experiments in pregnant ewes, we evaluate FOSTER's performance with both mixed maternal-fetal signals and isolated fetal components.
resultsProcessing isolated fetal signals improves estimation accuracy with respect to arterial blood oxygen saturation (SaO$_{2}$), showing improvements of 13.7% in mean absolute error (MAE) and 10.5% in Pearson correlation coefficient relative to using mixed TFO signals alone. A dual-branch neural network, processing mixed and isolated PPG signals simultaneously, achieves additional improvements of 6.3% in MAE and 4.1% in Pearson correlation compared to using isolated fetal signals alone.
conclusionThe FOSTER pipeline demonstrates significant improvements in continuous fSpO$_{2}$ estimation accuracy through advanced signal processing and a dual-branch architecture, establishing a foundation for reliable fSpO$_{2}$ monitoring. SIGNIFICANCE: This work represents an important innovative step toward accurate, continuous, and non-invasive monitoring of fetal oxygenation. The validated methods in animal studies establish a foundation for advancing the development of fetal monitoring systems, offering new possibilities for improved maternal-fetal care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.